Annual report
6063.TEDINET S100QGHJ
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥4.4bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥717m | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥236m | 2021-01-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥730m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥244m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2m | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥93m | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥142m | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥727m | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥254m | 2021-01-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥500m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥179m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥271,000 | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥63m | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥95m | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥500m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥179m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥3.9bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥2.6bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.6bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.3bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.7bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥867m | at 2020-12-31d | Cons. | Net assets |
| Net assets / equity | ¥877m | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥820m | at 2018-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥883m | at 2018-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥920m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥245m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥405m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥38m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥227m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥63m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥85m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥85m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥310m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥353m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥115m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥316m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥146m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥198.5 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.11 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.25 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.63 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥198.42 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.96 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.81 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.01 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥624.46 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥419.16 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥334.16 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥343 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥323.34 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 40.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.8% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 38.0% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 234 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 251 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 279 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 299 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 290 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥4.3bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.8bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥690m | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥211m | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥700m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥219m | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥15m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥103m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥113m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥698m | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥228m | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥477m | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥154m | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | −¥13m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥79m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥74m | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.6bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.4bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.7bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.3bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥803m | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥648m | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥662m | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥589m | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥189.49 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.31 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.11 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.84 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.9 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥189.42 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.27 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.28 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.42 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥18 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥488.31 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥308.82 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥247.56 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥256.85 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥229.65 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 34.1% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.9% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.8% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 47.5% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.0% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,519,600 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,487,600 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,473,200 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 169 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 179 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 197 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 205 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 188 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥19m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥6m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥390m |
| Life Assitance Departmentreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥26m |
| Life Assitance Departmentreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥10m |
| Life Assitance Departmentreportable segment | employees | at 2022-12-31 | 45 pure |
| Life Assitance Departmentreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥420m |
| Life Assitance Departmentreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥420m |
| Life Assitance Departmentreportable segment | segment assets | at 2022-12-31 | ¥33m |
| Life Assitance Departmentreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥160m |
| Medical Assistance Departmentreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥7m |
| Medical Assistance Departmentreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥39m |
| Medical Assistance Departmentreportable segment | employees | at 2022-12-31 | 165 pure |
| Medical Assistance Departmentreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥5.8bn |
| Medical Assistance Departmentreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥5.8bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2022-12-31 | ¥1.8bn |
| Medical Assistance Departmentreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥946m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥33m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥49m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥6.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥6.2bn |
| —segment total | segment assets | at 2022-12-31 | ¥1.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | ¥18m |
| Reconciling Itemsreconciling | depreciation | 2021-01-01 → 2021-12-31 | ¥5m |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥1.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥326m |
| Life Assitance Departmentreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥11m |
| Life Assitance Departmentreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥15m |
| Life Assitance Departmentreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥516m |
| Life Assitance Departmentreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥516m |
| Life Assitance Departmentreportable segment | segment assets | at 2021-12-31 | ¥15m |
| Life Assitance Departmentreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥319m |
| Medical Assistance Departmentreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥5m |
| Medical Assistance Departmentreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥42m |
| Medical Assistance Departmentreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥3.8bn |
| Medical Assistance Departmentreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥3.8bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2021-12-31 | ¥2.2bn |
| Medical Assistance Departmentreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥243m |
| —segment total | capex | 2021-01-01 → 2021-12-31 | ¥16m |
| —segment total | depreciation | 2021-01-01 → 2021-12-31 | ¥57m |
| —segment total | revenue | 2021-01-01 → 2021-12-31 | ¥4.4bn |
| —segment total | revenue external | 2021-01-01 → 2021-12-31 | ¥4.4bn |
| —segment total | segment assets | at 2021-12-31 | ¥2.2bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥562m |
| Life Assitance Departmentreportable segment | employees | at 2022-12-31 | 45 pure |
| Medical Assistance Departmentreportable segment | employees | at 2022-12-31 | 100 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,261
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 1568000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | － | JPY |
| Subcontract expenses sga | Prior1YearDuration | 51114000 | JPY |
| Subcontract expenses sga | CurrentYearDuration | 70881000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 3842122000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 516412000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 4358535000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 4358535000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 3842122000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 516412000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 4358535000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 4358535000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 242813000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 319025000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 561839000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | -326032000 | JPY |
| Operating income | Prior1YearDuration | 235806000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 2217178000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 14542000 | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 2231720000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 1571278000 | JPY |
| Assets | Prior1YearInstant | 3802999000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 41779000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 15318000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 57098000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | 4599000 | JPY |
| Depreciation segment information | Prior1YearDuration | 61698000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 5385000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 10692000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_ReportableSegmentsMember | 16077000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_ReconcilingItemsMember | 17604000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration | 33682000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 5821326000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 419892000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReportableSegmentsMember | 6241218000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYearDuration | 6241218000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration | － | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 5821326000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |